BTNA
TEVA icon

Bremer Trust National Association’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bremer Trust National Association’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$4K Buy
+247
New +$5.06K ﹤0.01% 716

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Bremer Trust National Association's TEVA Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q4 2018: 247 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #716 among its holdings.

552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • Bremer Trust National Association held 247 shares of Teva Pharmaceutical Industries Limited worth $4K as of Q4 2018.
  • Teva Pharmaceutical Industries Limited was a new Bremer Trust National Association position in Q4 2018.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #716 holding.
  • 552 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.